BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15312243)

  • 21. Osteoclast lineage and function.
    Väänänen HK; Laitala-Leinonen T
    Arch Biochem Biophys; 2008 May; 473(2):132-8. PubMed ID: 18424258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
    Rissanen JP; Suominen MI; Peng Z; Halleen JM
    Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calcium.
    Ylipahkala H; Halleen JM; Kaija H; Vihko P; Väänänen HK
    Biochem Biophys Res Commun; 2003 Aug; 308(2):320-4. PubMed ID: 12901871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased osteoclast activity is associated with aggressiveness of osteosarcoma.
    Avnet S; Longhi A; Salerno M; Halleen JM; Perut F; Granchi D; Ferrari S; Bertoni F; Giunti A; Baldini N
    Int J Oncol; 2008 Dec; 33(6):1231-8. PubMed ID: 19020756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
    Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
    Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanical strain effect on bone-resorbing activity and messenger RNA expressions of marker enzymes in isolated osteoclast culture.
    Kurata K; Uemura T; Nemoto A; Tateishi T; Murakami T; Higaki H; Miura H; Iwamoto Y
    J Bone Miner Res; 2001 Apr; 16(4):722-30. PubMed ID: 11316000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones.
    Xia L; Kilb J; Wex H; Li Z; Lipyansky A; Breuil V; Stein L; Palmer JT; Dempster DW; Brömme D
    Biol Chem; 1999 Jun; 380(6):679-87. PubMed ID: 10430032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
    Sasaki T
    Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
    Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
    J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cathepsins in the osteoclast.
    Goto T; Yamaza T; Tanaka T
    J Electron Microsc (Tokyo); 2003; 52(6):551-8. PubMed ID: 14756243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocytes/Macrophages Upregulate the Hyaluronidase HYAL1 and Adapt Its Subcellular Trafficking to Promote Extracellular Residency upon Differentiation into Osteoclasts.
    Puissant E; Boonen M
    PLoS One; 2016; 11(10):e0165004. PubMed ID: 27755597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological sequestration of intracellular cholesterol in late endosomes disrupts ruffled border formation in osteoclasts.
    Zhao H; Väänänen HK
    J Bone Miner Res; 2006 Mar; 21(3):456-65. PubMed ID: 16491294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts.
    Parikka V; Lehenkari P; Sassi ML; Halleen J; Risteli J; Härkönen P; Väänänen HK
    Endocrinology; 2001 Dec; 142(12):5371-8. PubMed ID: 11713237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocytosis of tartrate-resistant acid phosphatase by osteoblast-like cells is followed by inactivation of the enzyme.
    Perez-Amodio S; Jansen DC; Tigchelaar-Gutter W; Beertsen W; Everts V
    Calcif Tissue Int; 2006 Apr; 78(4):248-54. PubMed ID: 16604288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of the Man-6-P targeting pathway in mice impairs osteoclast secretory lysosome biogenesis.
    van Meel E; Boonen M; Zhao H; Oorschot V; Ross FP; Kornfeld S; Klumperman J
    Traffic; 2011 Jul; 12(7):912-24. PubMed ID: 21466643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRACP as an osteopontin phosphatase.
    Andersson G; Ek-Rylander B; Hollberg K; Ljusberg-Sjölander J; Lång P; Norgård M; Wang Y; Zhang SJ
    J Bone Miner Res; 2003 Oct; 18(10):1912-5. PubMed ID: 14584906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of the expression levels of lysosomal cysteine proteinases in purified human osteoclastic cells by competitive RT-PCR.
    Ishibashi O; Inui T; Mori Y; Kurokawa T; Kokubo T; Kumegawa M
    Calcif Tissue Int; 2001 Feb; 68(2):109-16. PubMed ID: 11310346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The mechanism of TRACP 5b maturation].
    Ohashi T; Ichimura S; Mochizuki Y; Miura T; Mogushi K; Ohashi W; Sato Y; Kojima R; Tanaka H; Igarashi Y; Nomura F; Katayama K; Miki T; Nishizawa Y
    Rinsho Byori; 2007 Apr; 55(4):325-9. PubMed ID: 17511262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur.
    Yamaza T; Goto T; Kamiya T; Kobayashi Y; Sakai H; Tanaka T
    Bone; 1998 Dec; 23(6):499-509. PubMed ID: 9855458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport.
    Hollberg K; Hultenby K; Hayman A; Cox T; Andersson G
    Exp Cell Res; 2002 Oct; 279(2):227-38. PubMed ID: 12243748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.